PI-LAB-2025-066

Gonadorelin, Independent Lab Report

Gonadorelin 2mg · NextGen Peptides

Verified

Independent testing verdict Pass

This product matched its label.

Identity confirmed and measured purity of 96.9% met the stated ≥98% claim. Content measured 101.6% of label.

Identity verified
Yes

Mass spectrometry confirmed the labelled compound

Measured purity
96.9%

Label claimed ≥98%

Content accuracy
101.5%

2.03mg measured against 2mg claimed

Test recency
Older result

Published 18 months ago

Specimen PI-LAB-2025-066 Tested by Chelsea Analytical Group 17 samples tested from this company Purity & Testing score 91/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 98% 96.9% Within analytical tolerance
Identity (MS) Gonadorelin Confirmed Matches label
Content 2 mg 2.03 mg Within 5% of label

Methodology & chain of custody

HPLC-UV purity, ESI-MS identity, and Karl Fischer water content.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Chelsea Analytical Group. See our full testing methodology.

Lot / batch
C1692-25
Purchased
Analysed
Published
Laboratory
Chelsea Analytical Group
Test type
Purity, identity & content

Original laboratory report: PI-LAB-2025-066-report.pdf (document delivery arrives with the production storage backend)

More Tests, NextGen Peptides

PT-141
Purity 98.5% Verified
Retatrutide
Purity 99.7% Verified
Tirzepatide/Cagrilintide Blend
Purity 97.6% Verified

More Tests, Gonadorelin

Gonadorelin Halcyon Biosciences
Purity 98.4% Verified
Gonadorelin NextGen Peptides
Purity 97.3% Discrepancy
Gonadorelin Halcyon Biosciences
Purity 99.5% Verified